Substituted benzoxazine and 3,4-dihydrobenzoxazine derivatives possessing activity as estrogen receptor beta (ER&bgr;) modulators are provided which have the structure of formula I
1
wherein the substitutents are as described herein.
In addition, a method is provided for preventing, inhibiting or treating the progression or onset of pathological conditions associated with the estrogen receptor and to pharmaceutical compositions containing such compounds.
本发明提供了具有
雌激素受体β(ER&bgr;)调节剂活性的取代苯并噁嗪和3,4-二氢苯并噁嗪衍
生物,其具有如公式I1所示的结构,其中取代基如此处所述。此外,本发明还提供了一种用于预防、抑制或治疗与
雌激素受体相关的病理状况的进展或发作的方法,并提供了包含这些化合物的药物组合物。